Cases 11 - 20 of 55
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Anacor Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2021cv01349
Plaintiff:
Anacor Pharmaceuticals, Inc. and PF PRISM IMB B.V.
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al
as 1:2021cv01106
Plaintiff:
Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant:
Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Dr. Reddys Laboratories, Inc. et al
as 1:2021cv01033
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.
Cause Of Action: 35 U.S.C. § 271
Bayer Healthcare LLC et al v. Dr. Reddy's Laboratories, Inc. et al
as 1:2021cv00997
Plaintiff:
Bayer Healthcare LLC, Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Pharma AG et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2021cv00732
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2021cv00695
Defendant:
Dr. Reddy's Laboratories Ltd. and Dr Reddy's Laboratories Inc.
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
